Literature DB >> 22505710

Human heat shock protein 105/110 kDa (Hsp105/110) regulates biogenesis and quality control of misfolded cystic fibrosis transmembrane conductance regulator at multiple levels.

Anita Saxena1, Yeshavanth K Banasavadi-Siddegowda, Yifei Fan, Sumit Bhattacharya, Gargi Roy, David R Giovannucci, Raymond A Frizzell, Xiaodong Wang.   

Abstract

Heat shock protein 105/110-kDa (Hsp105/110), a member of the Hsp70 super family of molecular chaperones, serves as a nucleotide exchange factor for Hsc70, independently prevents the aggregation of misfolded proteins, and functionally relates to Hsp90. We investigated the roles of human Hsp105α, the constitutively expressed isoform, in the biogenesis and quality control of the cystic fibrosis transmembrane conductance regulator (CFTR). In the endoplasmic reticulum (ER), Hsp105 facilitates CFTR quality control at an early stage in its biosynthesis but promotes CFTR post-translational folding. Deletion of Phe-508 (ΔF508), the most prevalent mutation causing cystic fibrosis, interferes with de novo folding of CFTR, impairing its export from the ER and accelerating its clearance in the ER and post-Golgi compartments. We show that Hsp105 preferentially associates with and stabilizes ΔF508 CFTR at both levels. Introduction of the Hsp105 substrate binding domain potently increases the steady state level of ΔF508 CFTR by reducing its early-stage degradation. This in turn dramatically enhances ΔF508 CFTR cell surface functional expression in cystic fibrosis airway epithelial cells. Although other Hsc70 nucleotide exchange factors such as HspBP1 and BAG-2 inhibit CFTR post-translational degradation in the ER through cochaperone CHIP, Hsp105 has a primary role promoting CFTR quality control at an earlier stage. The Hsp105-mediated multilevel regulation of ΔF508 CFTR folding and quality control provides new opportunities to understand how chaperone machinery regulates the homeostasis and functional expression of misfolded proteins in the cell. Future studies in this direction will inform therapeutics development for cystic fibrosis and other protein misfolding diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22505710      PMCID: PMC3365948          DOI: 10.1074/jbc.M111.297580

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

1.  Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome.

Authors:  M A Loo; T J Jensen; L Cui; Y Hou; X B Chang; J R Riordan
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

2.  Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions.

Authors:  C A Ballinger; P Connell; Y Wu; Z Hu; L J Thompson; L Y Yin; C Patterson
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

3.  Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator.

Authors:  A Vankeerberghen; L Wei; M Jaspers; J J Cassiman; B Nilius; H Cuppens
Journal:  Hum Mol Genet       Date:  1998-10       Impact factor: 6.150

4.  The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis.

Authors:  G C Meacham; Z Lu; S King; E Sorscher; A Tousson; D M Cyr
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

5.  Missense mutation (G480C) in the CFTR gene associated with protein mislocalization but normal chloride channel activity.

Authors:  L S Smit; T V Strong; D J Wilkinson; M Macek; M K Mansoura; D L Wood; J L Cole; G R Cutting; J A Cohn; D C Dawson
Journal:  Hum Mol Genet       Date:  1995-02       Impact factor: 6.150

6.  A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection.

Authors:  P L Zeitlin; L Lu; J Rhim; G Cutting; G Stetten; K A Kieffer; R Craig; W B Guggino
Journal:  Am J Respir Cell Mol Biol       Date:  1991-04       Impact factor: 6.914

7.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.

Authors:  G M Denning; M P Anderson; J F Amara; J Marshall; A E Smith; M J Welsh
Journal:  Nature       Date:  1992-08-27       Impact factor: 49.962

8.  The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells.

Authors:  G L Lukacs; X B Chang; C Bear; N Kartner; A Mohamed; J R Riordan; S Grinstein
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

9.  The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.

Authors:  Y Yang; S Janich; J A Cohn; J M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

10.  Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP.

Authors:  G L Lukacs; A Mohamed; N Kartner; X B Chang; J R Riordan; S Grinstein
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

View more
  24 in total

Review 1.  hERG quality control and the long QT syndrome.

Authors:  Brian Foo; Brittany Williamson; Jason C Young; Gergely Lukacs; Alvin Shrier
Journal:  J Physiol       Date:  2016-02-09       Impact factor: 5.182

2.  The Hsp70/J-protein machinery of the African trypanosome, Trypanosoma brucei.

Authors:  Stephen John Bentley; Miebaka Jamabo; Aileen Boshoff
Journal:  Cell Stress Chaperones       Date:  2018-12-01       Impact factor: 3.667

3.  Three epilepsy-associated GABRG2 missense mutations at the γ+/β- interface disrupt GABAA receptor assembly and trafficking by similar mechanisms but to different extents.

Authors:  Xuan Huang; Ciria C Hernandez; Ningning Hu; Robert L Macdonald
Journal:  Neurobiol Dis       Date:  2014-05-04       Impact factor: 5.996

4.  Interference with ubiquitination in CFTR modifies stability of core glycosylated and cell surface pools.

Authors:  Seakwoo Lee; Mark J Henderson; Eric Schiffhauer; Jordan Despanie; Katherine Henry; Po Wei Kang; Douglas Walker; Michelle L McClure; Landon Wilson; Eric J Sorscher; Pamela L Zeitlin
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

5.  A Proteomic Variant Approach (ProVarA) for Personalized Medicine of Inherited and Somatic Disease.

Authors:  Darren M Hutt; Salvatore Loguercio; Alexandre Rosa Campos; William E Balch
Journal:  J Mol Biol       Date:  2018-06-18       Impact factor: 5.469

6.  Hierarchical functional specificity of cytosolic heat shock protein 70 (Hsp70) nucleotide exchange factors in yeast.

Authors:  Jennifer L Abrams; Jacob Verghese; Patrick A Gibney; Kevin A Morano
Journal:  J Biol Chem       Date:  2014-03-26       Impact factor: 5.157

7.  Binding of human nucleotide exchange factors to heat shock protein 70 (Hsp70) generates functionally distinct complexes in vitro.

Authors:  Jennifer N Rauch; Jason E Gestwicki
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

Review 8.  High molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapy.

Authors:  Xiang-Yang Wang; John R Subjeck
Journal:  Int J Hyperthermia       Date:  2013-07-05       Impact factor: 3.914

9.  HDAC inhibitors rescue multiple disease-causing CFTR variants.

Authors:  Frédéric Anglès; Darren M Hutt; William E Balch
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

10.  Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation.

Authors:  Darren M Hutt; Salvatore Loguercio; Daniela Martino Roth; Andrew I Su; William E Balch
Journal:  J Biol Chem       Date:  2018-07-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.